Skip to main content
Cancer Explained
Donate

NewsIn memory

Nancy Reagan and Breast Cancer: A Public Diagnosis That Raised Awareness

Former First Lady Nancy Reagan shared her 1987 breast cancer diagnosis publicly. Here is a calm, plain-language look at what breast cancer is, from the National Cancer Institute.

By Cancer Explained Editorial TeamPublished Updated

A plain-language summary based on public reporting and trusted sources, linked below.

A woman in headscarf walks alone outdoors through a green wooded area
A woman in headscarf walks alone outdoors through a green wooded area — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

What was announced in 1987

UPI's White House correspondent filed the story on October 17, 1987. First Lady Nancy Reagan had a modified radical mastectomy at Bethesda Naval Hospital that morning, after a biopsy found what UPI reported as "a 7 millimeter tumor of non-invasive, intraductal adenocarcinoma."

The White House physician, Dr. John Hutton, said the laboratory examination showed "no evidence of malignancy in the lymph nodes or surrounding tissue." The White House said no chemotherapy or radiation was planned.

Standards of care in 1987 were not those of today, and this page makes no judgment about anyone's medical decisions. What is worth explaining is the test that started the sequence, because mammography is both more useful and more complicated than most coverage suggests.

What a mammogram is doing

A mammogram is a low-dose x-ray of compressed breast tissue. It is looking for two things: a mass with an irregular shape, and clusters of tiny calcium deposits called microcalcifications, which can be the only visible sign of very early disease.

The National Cancer Institute (NCI) sums up the evidence carefully. There is evidence that mammography decreases breast cancer mortality in women aged 50 to 69. For women aged 40 to 49, NCI states the benefit "is uncertain."

That is not a reason to skip screening. It is a reason to understand what you are agreeing to.

Current screening advice

The recommendation CDC relays comes from the US Preventive Services Task Force: women aged 40 to 74 at average risk should have a mammogram every two years.

People at higher risk, including those with a strong family history or a known inherited gene change, may be offered earlier or more frequent screening, sometimes with MRI. That is a conversation to have with your own clinician.

What screening finds, and what it misses

The recall numbers surprise most people. NCI reports that about 10% of American women are called back for further testing after a screening mammogram. Only 0.5% of women screened turn out to have cancer. So roughly 9.5% of women tested have a false-positive exam.

Over time this compounds. NCI reports that about 50% of women screened annually for 10 years in the US will have at least one false-positive exam. Of those, 7% to 17% will have a biopsy.

Missed cancers are the other side. NCI states that invasive breast cancer is present but undetected in 6% to 46% of mammograms. False negatives are more likely with mucinous and lobular cancers, with fast-growing tumors that appear between scheduled screens, and in dense breasts, which are more common in younger women.

Dense breast tissue appears white on a mammogram. So does a tumor. That is the whole problem, and it is why some women are offered additional imaging.

Radiation is not a serious concern. NCI states the exposure from a typical two-view mammogram is extremely unlikely to cause cancer.

Overdiagnosis, explained honestly

This is the hardest concept in cancer screening, and it deserves a plain explanation.

Some cancers found by screening would never have caused symptoms or shortened a life. There is currently no reliable way to tell those apart from the dangerous ones. So NCI notes that standard treatment is recommended for all of them, including patients who will not benefit.

The estimated scale is wide. NCI puts it at between 20% and 50% of screen-detected cancers, depending on age, life expectancy, and tumor type.

That is not an argument against screening. It is the reason screening is a considered decision rather than an automatic one, and the reason NCI increasingly recommends shared decision making.

What "non-invasive" and "intraductal" mean

Those two words carry a lot of weight, and they are worth knowing.

Ductal carcinoma in situ, often shortened to DCIS, describes abnormal cells confined inside a milk duct that have not broken through the duct wall into surrounding tissue. Because they have not invaded, they cannot have spread elsewhere. "Intraductal" means inside the duct. "Non-invasive" means it has not crossed that boundary.

DCIS is largely a product of mammography. It rarely forms a lump you can feel, and it is often detected only through microcalcifications on a screening image. NCI's PDQ summary quotes an American Cancer Society count of about 59,080 DCIS cases in the US for 2025.

Two other screening methods, and what the evidence says

Clinical breast examination, done by a clinician, has real limits. NCI reports specificity of 88% to 99% in women aged 50 to 59, and that 17% to 43% of women who have cancer have a normal clinical exam.

Breast self-examination is more complicated. NCI states flatly that it has been shown to have no benefit in reducing breast cancer mortality, based on two randomized trials.

That does not mean ignore your body. Knowing what is normal for you is how most symptomatic cancers get found. It means a monthly ritual has not been shown to save lives on its own, so it is not a substitute for screening.

Changes that need an appointment

Regardless of when your last mammogram was, ask to be seen for:

  • A new lump or firm thickening in the breast or armpit that persists past one menstrual cycle
  • Skin dimpling, puckering, or an orange-peel texture
  • A nipple that has newly turned inward
  • Spontaneous discharge from one nipple, especially bloody or clear
  • A scaly, itchy rash on the nipple lasting more than two weeks

Seek care within days for a breast that turns red, hot, swollen, and heavy over a few weeks. That can be infection, and it can be inflammatory breast cancer, which does not form a lump.

A normal recent mammogram does not rule out a new lump. Screening tests and symptoms are handled differently, and a symptom always earns its own workup.

Sources

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Breast cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI